Skip to main content
NCBI home page
International Journal of General Medicine logoLink to International Journal of General Medicine
. 2020 Mar 10;13:89–97. doi: 10.2147/IJGM.S249011

Major miRNA Involved in Insulin Secretion and Production in Beta-Cells

Mohsen Aghaei 1, Ali Khodadadian 1, Karimi-Nazari Elham 2, Majid Nazari 1, Emad Babakhanzadeh 1,3,✉
PMCID: PMC7071856  PMID: 32210605

Abstract

Insulin is implicated as a leading factor in glucose homeostasis and an important theme in diabetes mellitus (DM). Numerous proteins are involved in insulin signaling pathway and their dysregulation contributes to DM. microRNAs (miRNAs) as single-strand molecules have a critical effect on gene expression at post-transcriptional levels. Intensive investigation done by DM researchers disclosed that miRNAs have a significant role in insulin secretion by direct targeting numerous proteins engaged in insulin signaling pathway; so, their dysregulation contributes to DM. In this review, we presented some major miRNAs engaged in the insulin production and secretion.

Keywords: insulin, diabetes mellitus, microRNAs, insulin signaling pathway

Introduction

Insulin, as an endocrine hormone, serves as a mediator in glucose metabolism and energy storage. This spherical miniprotein hormone (5.8 kDa) is derived from the intermolecular disulfide bridge (CysA7-CysB7 and CysA20-CysB19) between peptide chains of the A-chain (Ins-A, 21 amino acid residues) that contains an intramolecular disulfide bridge (CysA6-CysA11) and B-chain (Ins-B, 30 amino acid residues).1 Pancreatic islets in mammals are rich in beta-cells and are assumed as the only source of circulating insulin.2 Freshly synthesized insulin in beta-cells is initially produced as the prohormone proinsulin. Later, it is converted into mature insulin by the prohormone convertase action (PC1, PC2, encoded by Pcsk1 and Pcsk2, respectively) during shuttling by the secretory pathway.1 Active insulin is kept in condensed core secretory granules (5–10,000 per cell),3 while each of these granules contains 300,000 or more molecules of insulin.2 According to the literature, changes in insulin secretion are one of the main reasons for the beginning of diabetes mellitus (DM).4 In the current research, we introduced the major pathways involved in insulin granule fusion, focused on most important miRNAs that contributed to insulin production and secretion, and finally discussed miRNA-therapy as a novel approach to alleviate diseases such as DM.

Proteins Involved in Docking and Fusion

High-affinity interaction between SNAREs, as highly conserved proteins, which are soluble N-ethylmaleimide-sensitive factor attachment protein receptor, has a significant effect on insulin granule docking, priming, and fusion. These proteins include synaptobrevin-2 (VAMP), stx-1, and SNAP-25 (25-kDa synaptosomal-associated protein): Stx-1 and SNAP25 are plasma membrane proteins and are named t-SNAREs (target SNAREs); VAMP exists in the vesicle or granule membrane and is often called v-SNAREs (vesicle SNAREs), in this protein as a homologous SNARE motif is composed of 60–70 amino acids. The four SNARE motifs (stx-1 has one SNARE motif, VAMP has a separate SNARE motif, while SNAP 25 has two SNARE motives) combine together to establish a ternary complex that has a significant effect on insulin granules’ fusion with the plasma membrane.5

The cAMP Role in Insulin Granule Exocytosis

The regulator activity of cAMP in various cellular functions of various cell types has changed cAMP into an important universal intracellular messenger.6 The cAMP generation from ATP is catalyzed by adenylyl cyclases (ACs) and 10 members of this enzyme family have been identified while their expressions in islet cell were proved.7 In insulin secretion, it has been long known that cAMP action is mediated by protein kinase A (PKA)8 of proteins associated with the secretory process through phosphorylation.

ATP-Sensitive Potassium Channel

The ATP-sensitive potassium channel (KATP channel) is a metabolic sensor, which is able to couple a cell’s metabolic status with electrical activity and adjusts various cellular functions. In pancreatic beta-cells, KATP channels regulate the secretion of insulin.9 With regard to structure, KATP channels, as large hetero-octameric complexes include four regulatory sulphonylurea receptors (SURx) and four pore-forming (Kir6.x) (via cytoplasmic domains bind to ATP) subunits, which are encoded by ABCC8 and KCNJ11, respectively.10,11 Considering the KATP channel activity, the membrane is held at a hyperpolarized level that results in voltage-gated Ca2+ channels’ closure.12 A rise in the serum glucose triggers the pancreatic beta-cell to uptake glucose through glucose transporter GLUT2. Later, glucose converts into ATP via subsequent mechanisms.10 By binding to Kir6.2, ATP closes the KATP channel; this closure can be facilitated by Epac2, which binds with the channel’s SUR1 subunit.13,14 As a result, a membrane depolarization is created that opens channels of the voltage-gated Ca2+ and initiates the beta-cell electrical activity as well as Ca2+ influx. Subsequently, increase in [Ca2+] stimulates the insulin release.12

G Protein-Coupled Receptor (GPCR)

G protein-coupled receptors (GPCR), as versatile, seven-transmembrane-domain proteins, are responsible for regulating various intracellular signaling arrays cascade in response to hormones, neurotransmitters, and ions.15 In this regard, G proteins include heterotrimer proteins consisting of the α, β, and γ subunits. Although G proteins differ basically in amino acid with regard to their sequence of the α-subunit, such as Gs, Gi, and Gq, many of them can couple with the GPCRs. Gs makes the adenylate cyclase active and increases production of cAMP and activates protein kinase A (PKA) and the Epac (exchange proteins that are activated by cAMP directly) family of cAMP-regulated guanine nucleotide exchange factors. Both PKA and Epac contain multiple downstream effectors in insulin secretion. Gi is responsible for inhibiting the adenylate cyclase and stimulating the mitogen-activated protein kinase (MAPK). In order to produce inositol 1,4,5-triphosphate (IP3) and diacylglycerol (DAG), Gq stimulates PLC-β. Finally, IP3 stimulates the Ca2+ release from the endoplasmic reticulum, while DAG makes protein kinase C active.16

MicroRNAs are introduced as a class of gene expression negative regulators involved in developing endocrine pancreas and regulating insulin secretion.17

Biogenesis and Maturation of miRNA

The miRNA genes, transcribed by RNA polymerase II (Pol II), are controlled by RNA Pol II-associated transcription factors and epigenetic regulators. In this regard, long primary transcript (pri-miRNA) that span over 1kb has a local hairpin structure, which contains miRNA sequences.18 The nuclear RNase III Drosha and DGCR8 create a complex: Microprocessor. This Microprocessor copies the stem–loop and initiates the maturation process in order to release a small hairpin-shaped RNA of ~65 nucleotides in length (pre-miRNA).19 After this export, pre-miRNA is cleaved next to the terminal loop by Dicer and liberates a small RNA duplex consisting of a passenger and guide strand.20 Subsequently, this RNA duplex forms the effector complex of RNA-induced silencing complex (RISC) after loading onto an AGO protein.21 Following the above-mentioned process, the pre-RISC (in which AGO proteins are associated with RNA duplexes) eliminates the passenger strand quickly and generates a mature RISC that performs gene silencing (Figure 1).22 Following miRNA duplex loading, the pre-RISC (in which AGO proteins associate with RNA duplexes) quickly removes the passenger strand to generate a mature RISC that performs gene silencing.23 In this review, we tried to introduce better miRNAs involved in insulin secretion and production (Table 1), Figure 2.

Figure 1.

Figure 1

Open in a new tab

Biogenesis and maturation of miRNA. miRNA genes are transcribed by RNA polymerase II, then long primary transcript (pri-miRNA) under cleavage by Drosha/DGCR8 complex to form a small hairpin-shaped RNA of ~65 nucleotides in length (pre-miRNA). After this, pre-miRNA is transmitted to the cytoplasm with the help of the XPO5/RanGTP complexes. Pre-miRNA is cleaved by Dicer next to the terminal loop. RNA duplex created by Dicer is subsequently loaded onto RISC complex and the passenger strand is removed. This complex can bind to their target mRNAs and lead to translational repression, mRNA degradation and even mRNA upregulation.

Table 1.

Selected miRNAs Involved in Insulin Secretion

miRNA Target Chromosome Location
miR-7 Akt, mTOR, and P70S6K Chromosome 924
miR-9 OC-2, Sirt1 Chromosome 1, 5, 1530
miR-29 p85α, Stx-1a Chromosome 1,742
miR-34a Sirt1 Chromosome 1, 1149
miR-124a Foxa2 Chromosome 14, 3,250,51
miR-143 ORP8 Chromosome 557
miR-153 SNAP-25 and VAMP-2 Chromosome 2,762
miR-187 HIPK3 Chromosome 1865
miR-204 GLP1R Chromosome 966
miR-375 Pdx-1, Mtpn, NeuroD1 Chromosome 271
Open in a new tab

Figure 2.

Figure 2

Open in a new tab

A summary of the major miRNAs involved in production and secretion of insulin and their interaction with targets.

miR-7

MiR-7, as an intronic miRNA, is mapped to the initial intron of heterogenous ribonuclear protein K gene on chromosome 9.24 MiR-7 has been evolutionarily conserved and has recently emerged as a prototypical neuroendocrine miRNA. Among the neurons and neuroendocrine organs most significantly enriched in miR-7 the endocrine pancreas, pituitary, and adrenal glands can be mentioned.25,26

The mTOR, as a serine/threonine kinase, acts as a growth regulator as well as nutrient sensor. It exists as part of two functionally and biochemically distinct complexes: mTOR complex1 (mTORC1) and mTOR complex 2 (mTORC2).27 The mTORC2 was found to mediate the phosphorylation of Akt/PKB at ser47. Phosphorylation Akt at ser 473 activates Akt for further phosphorylation in catalytic domain at Thr 308. Akt and 3-phosphoinositide –dependent protein kinase-1 (PDK1) trigger full activation of Akt, which is very important for glucose uptake.28 Furthermore, it was found that miR-7 down-regulated Akt, mTOR, and P70S6K transcription, which are considered as the major components of PI3K/Akt pathway.29

miR-9

MiR-9 is produced by mapping three genes of miR-9-1, miR-9-2, and miR-9-3 in the human genome to chromosomes 1, 5, and 15, respectively.30 MiR-9 mediate insulin exocytosis in insulin-producing cells through direct targeting Onecut-2 (OC-2) mRNA. As a result, decreased expression of the OC-2 can increase the Granuphilin levels, as its target gene. Additionally, it is well known that Granuphilin acts as a negative regulator of insulin secretion.31

The sirtuins family of proteins are NAD-dependent protein deacetylases involved in numerous physiological processes, such as apoptosis, cell growth, stress response, and energy metabolism.32–34 This family has been found to have seven members involving Sirt 1‑7. Mammalian Sirt1 is widely expressed in mammalian tissues and functions as a nuclear protein. As its main characteristic, mammalian Sirt1 can deacetylate histones’ co-regulators in a NAD-dependent manner and transcription factors.35–38 As a member of the mitochondrial inner membrane proteins, UCP2 has been implicated to promote proton leakage across the mitochondrial. In this way, UCP2 through decreasing ATP synthesis reduces insulin secretion. It is also of great importance that Sirt1 binds to the UCP2 promoter and abolishes UCP2 transcriptional activation. In this manner, Sirt1 regulates insulin secretion.39 Furthermore, recent investigations have introduced mir-9 as a key factor in modulating Sirt1 expression in the living organism. As Saunders et al40 reported, mir-9 targets Sirt1 in embryonic stem cells of rats. However, the intensive investigation conducted by Ramachandran et al41 showed that the above-mentioned process (mir-9 targeting of Sirt1) is a significant physiological process in insulin-secreting cells.

miR-29

The miR-29 family includes four mature members including miR-29a, miR-29b1, miR-29b2, and miR-29c. These members are encoded by two gene clusters of miR-29b2/miR-29c (mapped on chromosome 1q32) and miR-29b1/miR-29a (mapped on chromosome 7q32).42 Heterodimer-type (Class I) PI3Ks consists of a regulatory subunit that is at least encoded by three distinct genes (85α, p85β, p55γ) and a p110 catalytic subunit.43 The p85α is the most frequently expressed regulatory isoform of PI3K, which encodes two minor alternative splicing isoforms of p55a and p50a additionally.44 It also binds to tyrosine-phosphorylated proteins, like Insulin Receptor Substrate-1 (IRS-1), and activates PI3K activity of the pll0 subunit in insulin signaling.45 The miR-29 targets p85α directly and affects insulin signaling. Furthermore, miR-29 develops gluconeogenesis by aiming at hepatic p85α and enhancing expression of the phosphoenolpyruvate carboxykinase (PEPCK).46

As we mentioned previously, syntaxin-1a (Stx-1a) is an important factor in insulin granule fusion with the plasma membrane. An experimental study conducted by Bagge et al47 over INS-1E cells disclosed that miR-29a targeted the Stx-1a transcript directly and decreased Stx-1a mRNA and protein levels.

miR-34a

Among the mammalians, the family of miR-34 includes three processed miRNAs that reside in two various genes of miR-34a and miR-34b/c, which are located on 1p36 and 11q23, respectively.48 The researchers found that miR-34a affects the hepatic insulin signaling by targeting Sirtuin 1 (SIRT1).49

miR-124a

MiR-124a family, which is mainly expressed in the brain and pancreas, includes three processed miRNAs, which are encoded by three various genes of miR-124a1, miR-124a2, and miR-124a3, which are located on chromosome 14, chromosome 3, and chromosome 2, respectively.50,51 Forkhead box A2 (FOXA2)/Hepatocyte Nuclear Factor 3β (HNF3β) is a member of the forkhead box family and belongs to the liver transcription factors including FOXA1 and FOXA3 (or HNF3α, HNF3γ).52 We should also consider these factors’ conserved DNA binding domain and binding (as monomers) to the DNA elements that are homologous with the consensus sequence 5′- T(G/A)TTT(A/G)(C/T)T-3′.53,54 Different levels of FOXA2 expression (high and low) are observed in the liver and other tissues, respectively.55 FOXA2, as a transcriptional activator of Pdx-1, Sur1, preproinsulin, and Kir6.2 has been implicated in pancreatic beta-cell. So, FOXA2 protein over-production triggers the up-regulation of Kir6.2, Pdx-1, Sur-1, and preproinsulin mRNA expression.51,56 Recent investigations demonstrated that miR-124a2 had a crucial effect on insulin secretion by targeting at Foxa2 gene, which regulates insulin secretion.17

miR-143

The miR-143 has a highly conserved sequence belongs to the miR-143/145 family. It was also found that miR-143 was mapped to chromosome 5.57 The oxysterol-binding protein (OSBP) as well as OSBP-related proteins (ORPs) form a large family of genes that include sterol/lipid transportations and regulatory activities.58 ORP8 is located on the endoplasmic reticulum (ER) by its C-terminal transmembrane span and is bound to 25-hydroxycholesterol, which has changed it into a new ER oxysterol-binding protein. According to the literature, ORP8 was most highly expressed in the liver, macrophages, spleen, kidney, and brain and functioned in insulin signaling.59 Moreover, PIP2 concentration was considered as a phospholipase C (PLC) substrate that hydrolyzes PIP2 to PIP3 and is modulated by ORP8. As a result of binding IP3 to IP3R in the ER, Ca2+ releases to the cytosol.60 A recent study showed that miR-143 plays an important role in insulin secretion by targeting oxysterol-binding-protein-related protein 8 (ORP8).61

miR-153

Two copies of miR-153 have been known: A) miR-153-1, which is mapped to a highly conserved region in the intron 19 of IA-2 on chromosome 2 and B) miR-153-2, which resides in a highly conserved intronic region between exon 19 and 20 of IA-2β on chromosome 7. As mentioned previously, SNAP-25 and VAMP-2 are required for insulin granule fusion. Recent investigations disclosed that miR-153 played a crucial role in insulin secretion by targeting SNAP-25 and VAMP-2 directly.62

miR-187

Homeodomain-interacting protein kinases (HIPK1, HIPK2, HIPK3) can interact with the homeobox transcription factors Nkx-1.2.63 HIPK3 acts as a novel positive regulator of pdx-1 abundance through phosphorylation of pdx-1 (positive regulator of insulin biosynthesis).64 It is also a direct target of miR-187 with down-regulated expression levels in pancreatic islets of patients with type 2 diabetes.65

miR-204

MiR-204, as a highly beta-cell-enriched microRNA, is localized within large intron 6 of TRPM3 and mapped to chromosome 9q21.12.66 Glucagon-like peptide 1 receptor (GLP1R), as a GPCR, is composed of seven transmembrane domains.67 Increased dosage of GLP1R was reported in pancreatic beta-cells. It also has an important effect on the GLP-1, as the main incretin created in intestinal L-cells and pancreatic islet alpha cells.68,69 Food-stimulated GLP-1 secretion and its binding to the GLP1R triggers glucose-induced beta-cell insulin secretion via elevation of cAMP concentration.70 Jo et al discovered that the 3ʹUTR of GLP1R was a direct target for miR-204 in the beta-cell-derived rat INS-1 cell line as well as the primary mouse and human islets; thereby, the expression was down-regulated. In this manner, miR-204 acts as a negative regulator in insulin secretion.70

miR-375

Structural organization of MiR-375 gene on human chromosome 2 shows an intergenic spacer between CRYBA2 and CCDC108 genes.71 Pdx-1 is a homeodomain protein with a critical role in pancreatic β-cell function and development.72,73 Furthermore, insulin transcription activation resulted from Pdx-1, which is bound to the conserved AT-rich A3 box (−201/-196 bp). However, this protein acts as a repressor in other gene contexts.74 At low glucose concentrations (1–2mM) in β cells, the nuclear periphery is the main location of Pdx-1. Following the insulin secretion stimulation, Pdx-1 shuttles into the nucleus as a consequence of its phosphorylation. Atypical protein kinase C isoforms, p38/stress-activated protein kinase, glycogen synthase kinase 3 (GSK3), phosphatidylinositol 3-kinase (PI3K), Per-Arnt-Sim (PAS) kinase, and mitogen-activated protein kinase (MAPK) are among the main signaling pathways that adjust shuttling of the nucleo-cytoplasmic and adjust the Pdx-1 transactivation potential.75 Furthermore, it was disclosed that the Pdx-1 interaction with different transcriptional coregulators was mediated by glucose. Additionally, it was approved that expression of insulin gene under low and non-insulin stimulating glucose concentrations decreased by association of Pdx-1 with the histone deacetylases HDAC-1 and HDAC-2.76 Furthermore, Pdx-1 SUMOylation regulates its localization and stability. It is also associated with increased activity of insulin promoter.77 In addition, SUMOylation of Pdx-1 increases its nuclear localization as well as its protein stability and is correlated with an increase in insulin promoter activity.78 Finally, Pdx-1 is composed of at least two sites of O-GlcNAcylation, which promote its DNA activity of binding.79,80 A research indicated that miR-375 regulated insulin secretion by targeting Pdx-1.81

Myotrophin with ankyrin repeats mediates the protein–protein interactions in other proteins. Myotrophin functions to remodel F-actin filaments and secretory granules exocytosis.82 Furthermore, the literature found that miR-375 targets myotrophin mRNA.83

NeuroD1/Beta2 is a basic helix-loop-helix (bHLH) transcription factor that binds with the ubiquitously expressed E-box proteins at the conserved insulin E1 (−100/-91bp) site in a complex.84 O-GlcNAcylation of NeuroD185 as a crucial factor for its translocation to the nucleus is mediated by high glucose levels. It was disclosed that miR-375 targets NeuroD1 mRNA.81

Conclusion

Insulin secretion plays an important role in preventing hyper- and hypo-glycemic states and its defect develops diabetes mellitus. The miRNAs, which have a significant impact on various disease processes, emerged as important players of gene regulation. Deregulated expression of miRNA has been widely implicated in the insulin-secreting pancreatic beta-cell of patients with type-2 diabetes. As a result, impaired insulin secretion is a major factor in disease progression. So, a more in-depth understanding of the interplay between miRNAs and protein involved in insulin production and secretion may afford valuable insights and novel therapeutic strategies to treat diabetes.

Acknowledgment

The authors would like to thank Dr. S. Mirjalili, Dr. Montazeri, and Mr. Heydarian for their valuable support.

Abbreviations

miRNA, microRNA; DM, diabetes mellitus; PC, prohormone convertase; AC, adenylyl cyclase; SUR, sulphonylurea receptor; GPCR, G protein-coupled receptors; PKA, protein kinase A; MAPK, mitogen-activated protein kinase; IP3, produce inositol 1, 4, 5-triphosphate; DAG, diacylglycerol; PEPCK, phosphoenolpyruvate carboxykinase; Stx-1a, syntaxin-1a; FOXA2, Forkhead box A2; HNF3β, Hepatocyte Nuclear Factor 3β; OSBP: oxysterol-binding protein; HIPK, Homeodomain-interacting protein kinases; GLP1R, Glucagon-like peptide 1 receptor.

Author Contributions

All authors contributed to data analysis, drafting and revising the article, gave final approval of the version to be published, and agree to be accountable for all aspects of the work.

Disclosure

All authors declare that they have no conflicts of interest.

References

  • 1.Liu M, Weiss MA, Arunagiri A, et al. Biosynthesis, structure, and folding of the insulin precursor protein. Diabetes Obes Metab. 2018;20:28–50. doi: 10.1111/dom.13378 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Rutter GA, Pullen T, Hodson D, et al. Pancreatic β-cell identity, glucose sensing and the control of insulin secretion. Biochem J. 2015;466(2):203–218. doi: 10.1042/BJ20141384 [DOI] [PubMed] [Google Scholar]
  • 3.Fava E, Dehghany J, Ouwendijk J, et al. Novel standards in the measurement of rat insulin granules combining electron microscopy, high-content image analysis and in silico modelling. Diabetologia. 2012;55(4):1013–1023. doi: 10.1007/s00125-011-2438-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Fernández-Real J, Pickup J. Innate immunity, insulin resistance and type 2 diabetes. Diabetologia. 2012;55(2):273–278. doi: 10.1007/s00125-011-2387-y [DOI] [PubMed] [Google Scholar]
  • 5.Yin P. Architecture and Function of the Insulin Granule Secretion Machinery. Acta Universitatis Upsaliensis; 2018. [Google Scholar]
  • 6.Seino S, Takahashi H, Fujimoto W, et al. Roles of cAMP signalling in insulin granule exocytosis. Diabetes Obes Metab. 2009;11(s4):180–188. doi: 10.1111/dom.2009.11.issue-s4 [DOI] [PubMed] [Google Scholar]
  • 7.Roger B, Papin J, Vacher P, et al. Adenylyl cyclase 8 is central to glucagon-like peptide 1 signalling and effects of chronically elevated glucose in rat and human pancreatic beta-cells. Diabetologia. 2011;54(2):390–402. doi: 10.1007/s00125-010-1955-x [DOI] [PubMed] [Google Scholar]
  • 8.Sonoda N, Imamura T, Yoshizaki T, et al. β-arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic β cells. Proc Natl Acad Sci. 2008;105(18):6614–6619. doi: 10.1073/pnas.0710402105 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Quan Y, Barszczyk A, Feng Z-P, et al. Current understanding of K ATP channels in neonatal diseases: focus on insulin secretion disorders. Acta Pharmacol Sin. 2011;32(6):765. doi: 10.1038/aps.2011.57 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Stuhlmann T, Planells-Cases R, Jentsch TJ. LRRC8/VRAC anion channels enhance β-cell glucose sensing and insulin secretion. Nat Commun. 2018;9(1):1974. doi: 10.1038/s41467-018-04353-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Real J, Miranda C, Olofsson CS, et al. Lipophilicity predicts the ability of nonsulphonylurea drugs to block pancreatic beta‐cell KATP channels and stimulate insulin secretion; statins as a test case. Endocrinol Diabetes Metab. 2018;1(2):e00017. doi: 10.1002/edm2.2018.1.issue-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Ashcroft F. KATP Channels and Insulin Secretion: A Key Role in Health and Disease. Portland Press Limited; 2006. [DOI] [PubMed] [Google Scholar]
  • 13.Trapp S, Tucker SJ, Ashcroft FM. Activation and inhibition of K-ATP currents by guanine nucleotides is mediated by different channel subunits. Proc Natl Acad Sci USA. 1997;94(16):8872–8877. doi: 10.1073/pnas.94.16.8872 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Ozaki N, Shibasaki T, Kashima Y, et al. cAMP-GEFII is a direct target of cAMP in regulated exocytosis. Nat Cell Biol. 2000;2(11):805. doi: 10.1038/35041046 [DOI] [PubMed] [Google Scholar]
  • 15.Hilger D, Masureel M, Kobilka BK. Structure and dynamics of GPCR signaling complexes. Nat Struct Mol Biol. 2018;25(1):4. doi: 10.1038/s41594-017-0011-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Ahrén B. Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes. Nat Rev Drug Discov. 2009;8(5):369. doi: 10.1038/nrd2782 [DOI] [PubMed] [Google Scholar]
  • 17.Sebastiani G, Mancarella F, Ventriglia G, Nigi L, Valentini M, GE Grieco. MicroRNA miR-124a, a negative regulator of insulin secretion, is hyperexpressed in human pancreatic islets of type 2 diabetic patients. RNA Dis. 2015;2(2). [Google Scholar]
  • 18.Ha M, Kim VN. Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol. 2014;15(8):509. doi: 10.1038/nrm3838 [DOI] [PubMed] [Google Scholar]
  • 19.Han J, Lee Y, Yeom KH, Kim YK, Jin H, Kim VN. The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev. 2004;18(24):3016–3027. doi: 10.1101/gad.1262504 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Yi R, Qin Y, Macara IG, Cullen BR. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev. 2003;17(24):3011–3016. doi: 10.1101/gad.1158803 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Ketting RF, Fischer SE, Bernstein E, Sijen T, Hannon GJ, Plasterk RH. Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans. Genes Dev. 2001;15(20):2654–2659. doi: 10.1101/gad.927801 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Hammond SM, Boettcher S, Caudy AA, Kobayashi R, Hannon GJ. Argonaute2, a link between genetic and biochemical analyses of RNAi. Science. 2001;293(5532):1146–1150. doi: 10.1126/science.1064023 [DOI] [PubMed] [Google Scholar]
  • 23.Winter J, Jung S, Keller S, et al. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol. 2009;11(3):228. doi: 10.1038/ncb0309-228 [DOI] [PubMed] [Google Scholar]
  • 24.Reddy SDN, Ohshiro K, Rayala SK, et al. MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions. Cancer Res. 2008;68(20):8195–8200. doi: 10.1158/0008-5472.CAN-08-2103 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Landgraf P, Rusu M, Sheridan R, et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell. 2007;129(7):1401–1414. doi: 10.1016/j.cell.2007.04.040 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Joglekar MV, Joglekar VM, Hardikar AA. Expression of islet-specific microRNAs during human pancreatic development. Gene Expr Patterns. 2009;9(2):109–113. doi: 10.1016/j.gep.2008.10.001 [DOI] [PubMed] [Google Scholar]
  • 27.Yoon M-S, Choi CS. The role of amino acid-induced mammalian target of rapamycin complex 1 (mTORC1) signaling in insulin resistance. Exp Mol Med. 2017;48(1):e201. doi: 10.1038/emm.2015.93 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Zoncu R, Efeyan A, Sabatini DM. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol. 2011;12(1):21. doi: 10.1038/nrm3025 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Fang Y, Xue J-L, Shen Q, et al. MicroRNA‐7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3‐kinase/Akt pathway in hepatocellular carcinoma. Hepatology. 2012;55(6):1852–1862. doi: 10.1002/hep.25576 [DOI] [PubMed] [Google Scholar]
  • 30.Cekaite L, Rantala JK, Bruun J. et al. MiR-9, -31, and −182 deregulation promote proliferation and tumor cell survival in colon cancer. Neoplasia. 2012;14(9):868–879. doi: 10.1593/neo.121094 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Kato T, Shimano H, Yamamoto T, et al. Granuphilin is activated by SREBP-1c and involved in impaired insulin secretion in diabetic mice. Cell Metab. 2006;4(2):143–154. doi: 10.1016/j.cmet.2006.06.009 [DOI] [PubMed] [Google Scholar]
  • 32.Finkel T, Deng CX, Mostoslavsky R. Recent progress in the biology and physiology of sirtuins. Nature. 2009;460(7255):587–591. doi: 10.1038/nature08197 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Bagul K.P., Banerjee S. K, Insulin resistance, oxidative stress and cardiovascular complications: role of sirtuins. Curr Pharm Des. 2013;19(32):5663–5677. [DOI] [PubMed] [Google Scholar]
  • 34.Chen YR, Lai Y-L, Lin S-D, et al. SIRT1 interacts with metabolic transcriptional factors in the pancreas of insulin-resistant and calorie-restricted rats. Mol Biol Rep. 2013;40(4):3373–3380. doi: 10.1007/s11033-012-2412-3 [DOI] [PubMed] [Google Scholar]
  • 35.Langley E, Pearson M, Faretta M, et al. Human SIR2 deacetylates p53 and antagonizes PML/p53‐induced cellular senescence. EMBO J. 2002;21(10):2383–2396. doi: 10.1093/emboj/21.10.2383 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Vaquero A, Scher M, Lee D, et al. Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin. Mol Cell. 2004;16(1):93–105. doi: 10.1016/j.molcel.2004.08.031 [DOI] [PubMed] [Google Scholar]
  • 37.Vaquero A, Scher M, Erdjument-Bromage H, et al. SIRT1 regulates the histone methyl-transferase SUV39H1 during heterochromatin formation. Nature. 2007;450(7168):440–444. doi: 10.1038/nature06268 [DOI] [PubMed] [Google Scholar]
  • 38.Wang RH, Kim H-S, Xiao C, et al. Hepatic Sirt1 deficiency in mice impairs mTorc2/Akt signaling and results in hyperglycemia, oxidative damage and insulin resistance. J Clin Invest. 2011;121(11). doi: 10.1172/JCI46243 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Bordone L, Motta MC, Picard F, et al. Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic β cells. PLoS Biol. 2005;4(2):e31. doi: 10.1371/journal.pbio.0040031 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Saunders LR, Sharma AD, Tawney J, et al. miRNAs regulate SIRT1 expression during mouse embryonic stem cell differentiation and in adult mouse tissues. Aging (Albany NY). 2010;2(7):415. doi: 10.18632/aging.v2i7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Ramachandran D, Roy U, Garg S, et al. Sirt1 and mir‐9 expression is regulated during glucose‐stimulated insulin secretion in pancreatic β‐islets. FEBS J. 2011;278(7):1167–1174. doi: 10.1111/j.1742-4658.2011.08042.x [DOI] [PubMed] [Google Scholar]
  • 42.Mazzoccoli L, Robaina MC, Apa AG, et al. MiR-29 silencing modulates the expression of target genes related to proliferation, apoptosis and methylation in Burkitt lymphoma cells. J Cancer Res Clin Oncol. 2018;144(3):483–97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Pons S, Asano T, Glasheen E, et al. The structure and function of p55PIK reveal a new regulatory subunit for phosphatidylinositol 3-kinase. Mol Cell Biol. 1995;15(8):4453–4465. doi: 10.1128/MCB.15.8.4453 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Fruman DA, Cantley LC, Carpenter CL. Structural organization and alternative splicing of the murine phosphoinositide 3-kinase p85α gene. Genomics. 1996;37(1):113–121. doi: 10.1006/geno.1996.0527 [DOI] [PubMed] [Google Scholar]
  • 45.Suzuki H, Terauchi Y, Fujiwara M, Aizawa S, Yazaki Y, Kadowaki T, Koyasu S. Xid-like immunodeficiency in mice with disruption of the p85α subunit of phosphoinositide 3-kinase. Science. 1999;283(5400):390–392. doi: 10.1126/science.283.5400.390 [DOI] [PubMed] [Google Scholar]
  • 46.Pandey AK, Verma G, Vig S, et al. miR-29a levels are elevated in the db/db mice liver and its overexpression leads to attenuation of insulin action on PEPCK gene expression in HepG2 cells. Mol Cell Endocrinol. 2011;332(1):125–133. doi: 10.1016/j.mce.2010.10.004 [DOI] [PubMed] [Google Scholar]
  • 47.Bagge A, Dahmcke CM, Dalgaard LT. Syntaxin-1a is a direct target of miR-29a in insulin-producing β-cells. Horm Metab Res. 2013;45(06):463–466. doi: 10.1055/s-00000025 [DOI] [PubMed] [Google Scholar]
  • 48.Hermeking H. The miR-34 family in cancer and apoptosis. Cell Death Differ. 2010;17(2):193. doi: 10.1038/cdd.2009.56 [DOI] [PubMed] [Google Scholar]
  • 49.Lee J, Padhye A, Sharma A, et al. A pathway involving farnesoid X receptor and small heterodimer partner positively regulates hepatic sirtuin 1 levels via microRNA-34a inhibition. J Biol Chem. 2010;285(17):12604–12611. doi: 10.1074/jbc.M109.094524 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Baroukh NN, Van Obberghen E. Function of microRNA‐375 and microRNA‐124a in pancreas and brain. FEBS J. 2009;276(22):6509–6521. doi: 10.1111/j.1742-4658.2009.07353.x [DOI] [PubMed] [Google Scholar]
  • 51.Baroukh N, Ravier MA, Loder MK, et al. MicroRNA-124a regulates Foxa2 expression and intracellular signaling in pancreatic β-cell lines. J Biol Chem. 2007;282(27):19575–19588. doi: 10.1074/jbc.M611841200 [DOI] [PubMed] [Google Scholar]
  • 52.Friedman J, Kaestner K. The Foxa family of transcription factors in development and metabolism. Cell Mol Life Sci. 2006;63(19):2317–2328. doi: 10.1007/s00018-006-6095-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Overdier DG, Porcella A, Costa RH. The DNA-binding specificity of the hepatocyte nuclear factor 3/forkhead domain is influenced by amino-acid residues adjacent to the recognition helix. Mol Cell Biol. 1994;14(4):2755–2766. doi: 10.1128/MCB.14.4.2755 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Rada-Iglesias A, Wallerman O, Koch C, et al. Binding sites for metabolic disease related transcription factors inferred at base pair resolution by chromatin immunoprecipitation and genomic microarrays. Hum Mol Genet. 2005;14(22):3435–3447. doi: 10.1093/hmg/ddi378 [DOI] [PubMed] [Google Scholar]
  • 55.Kaestner KH, Hiemisch H, Luckow B, et al. The HNF-3 gene family of transcription factors in mice: gene structure, cDNA sequence, and mRNA distribution. Genomics. 1994;20(3):377–385. doi: 10.1006/geno.1994.1191 [DOI] [PubMed] [Google Scholar]
  • 56.Lantz KA, Vatamaniuk MZ, Brestelli JE, et al. Foxa2 regulates multiple pathways of insulin secretion. J Clin Invest. 2004;114(4):512–520. doi: 10.1172/JCI21149 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Li B, Fan J, Chen N. A novel regulator of type II diabetes: microRNA-143. Trends Endocrinol Metab. 2018;29(6):380–388. doi: 10.1016/j.tem.2018.03.019 [DOI] [PubMed] [Google Scholar]
  • 58.Charman M, Colbourne TR, Pietrangelo A, et al. Oxysterol-binding protein (OSBP)-related protein 4 (ORP4) is essential for cell proliferation and survival. J Biol Chem. 2014;289(22):15705–15717. doi: 10.1074/jbc.M114.571216 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Yan D, Mäyränpää MI, Wong J, et al. OSBP-related protein 8 (ORP8) suppresses ABCA1 expression and cholesterol efflux from macrophages. J Biol Chem. 2008;283(1):332–340. doi: 10.1074/jbc.M705313200 [DOI] [PubMed] [Google Scholar]
  • 60.Pulli I, Lassila T, Pan G, et al. Oxysterol-binding protein related-proteins (ORPs) 5 and 8 regulate calcium signaling at specific cell compartments. Cell Calcium. 2018;72:62–69. doi: 10.1016/j.ceca.2018.03.001 [DOI] [PubMed] [Google Scholar]
  • 61.Jordan SD, Krüger M, Willmes DM, et al. Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism. Nat Cell Biol. 2011;13(4):434–446. doi: 10.1038/ncb2211 [DOI] [PubMed] [Google Scholar]
  • 62.Mandemakers W, Abuhatzira L, Xu H, et al. Co-regulation of intragenic microRNA miR-153 and its host gene Ia-2β: identification of miR-153 target genes with functions related to IA-2β in pancreas and brain. Diabetologia. 2013;56(7):1547–1556. doi: 10.1007/s00125-013-2901-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.van der Laden J, Soppa U, Becker W. Effect of tyrosine autophosphorylation on catalytic activity and subcellular localisation of homeodomain-interacting protein kinases (HIPK). Cell Commun Signal. 2015;13(1):3. doi: 10.1186/s12964-014-0082-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Shojima N, Hara K, Fujita H, et al. Depletion of homeodomain-interacting protein kinase 3 impairs insulin secretion and glucose tolerance in mice. Diabetologia. 2012;55(12):3318–3330. doi: 10.1007/s00125-012-2711-1 [DOI] [PubMed] [Google Scholar]
  • 65.Locke J, da Silva Xavier G, Dawe HR, et al. Increased expression of miR-187 in human islets from individuals with type 2 diabetes is associated with reduced glucose-stimulated insulin secretion. Diabetologia. 2014;57(1):122–128. doi: 10.1007/s00125-013-3089-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Mikhaylova O, Stratton Y, Hall D, et al. VHL-regulated MiR-204 suppresses tumor growth through inhibition of LC3B-mediated autophagy in renal clear cell carcinoma. Cancer Cell. 2012;21(4):532–546. doi: 10.1016/j.ccr.2012.02.019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Thorens B. Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1. Proc Natl Acad Sci. 1992;89(18):8641–8645. doi: 10.1073/pnas.89.18.8641 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Lamont BJ, Li Y, Kwan E, et al. Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice. J Clin Invest. 2012;122(1):388–402. doi: 10.1172/JCI42497 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Mondal P, Song W-J, Li Y, et al. Increasing β-cell mass requires additional stimulation for adaptation to secretory demand. Mol Endocrinol. 2015;29(1):108–120. doi: 10.1210/me.2014-1265 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Jo S, Chen J, Xu G, et al. miR-204 controls glucagon-like peptide 1 receptor expression and agonist function. Diabetes. 2018;67(2):256–264. doi: 10.2337/db17-0506 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Chakraborty C, Doss CGP, Bandyopadhyay S, et al. Influence of miRNA in insulin signaling pathway and insulin resistance: micro‐molecules with a major role in type‐2 diabetes. Wiley Interdiscip Rev RNA. 2014;5(5):697–712. doi: 10.1002/wrna.1240 [DOI] [PubMed] [Google Scholar]
  • 72.Stoffers DA, Thomas MK, Habener JF. Homeodomain protein IDX-1: a master regulator of pancreas development and insulin gene expression. Trends Endocrinol Metab. 1997;8(4):145–151. doi: 10.1016/S1043-2760(97)00008-8 [DOI] [PubMed] [Google Scholar]
  • 73.Jonsson J, Ahlgren U, Edlund T, Edlund H. IPF1, a homeodomain protein with a dual function in pancreas development. Int J Dev Biol. 2003;39(5):789–798. [PubMed] [Google Scholar]
  • 74.Wang H, Maechler P, Ritz-Laser B, et al. Pdx1 level defines pancreatic gene expression pattern and cell lineage differentiation. J Biol Chem. 2001;276(27):25279–25286. doi: 10.1074/jbc.M101233200 [DOI] [PubMed] [Google Scholar]
  • 75.Vanderford NL, Cantrell JEL, Popa GJ, et al. Multiple kinases regulate mafA expression in the pancreatic beta cell line MIN6. Arch Biochem Biophys. 2008;480(2):138–142. doi: 10.1016/j.abb.2008.10.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Mosley AL, Özcan S. The pancreatic duodenal homeobox-1 protein (Pdx-1) interacts with histone deacetylases Hdac-1 and Hdac-2 on low levels of glucose. J Biol Chem. 2004;279(52):54241–54247. doi: 10.1074/jbc.M410379200 [DOI] [PubMed] [Google Scholar]
  • 77.Mosley AL, Özcan S. Glucose regulates insulin gene transcription by hyperacetylation of histone h4. J Biol Chem. 2003;278(22):19660–19666. doi: 10.1074/jbc.M212375200 [DOI] [PubMed] [Google Scholar]
  • 78.Kishi A, Nakamura T, Nishio Y, et al. Sumoylation of Pdx1 is associated with its nuclear localization and insulin gene activation. Am J Physiol Endocrinol Metab. 2003;284(4):. doi: 10.1152/ajpendo.00390.2002 [DOI] [PubMed] [Google Scholar]
  • 79.Gao Y, Miyazaki JI, Hart GW. The transcription factor PDX-1 is post-translationally modified by O-linked N-acetylglucosamine and this modification is correlated with its DNA binding activity and insulin secretion in min6 β-cells. Arch Biochem Biophys. 2003;415(2):155–163. doi: 10.1016/S0003-9861(03)00234-0 [DOI] [PubMed] [Google Scholar]
  • 80.Kebede M, Ferdaoussi M, Mancini A, et al. Glucose activates free fatty acid receptor 1 gene transcription via phosphatidylinositol-3-kinase-dependent O-GlcNAcylation of pancreas-duodenum homeobox-1. Proc Natl Acad Sci. 2012;109(7):2376–2381. doi: 10.1073/pnas.1114350109 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Keller DM, McWeeney S, Arsenlis A, et al. Characterization of pancreatic transcription factor Pdx-1 binding sites using promoter microarray and serial analysis of chromatin occupancy. J Biol Chem. 2007;282(44):32084–32092. doi: 10.1074/jbc.M700899200 [DOI] [PubMed] [Google Scholar]
  • 82.Poy MN, Eliasson L, Krutzfeldt J, et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature. 2004;432(7014):226. doi: 10.1038/nature03076 [DOI] [PubMed] [Google Scholar]
  • 83.Ghelani HS, Rachchh MA, Gokani RH. MicroRNAs as newer therapeutic targets: a big hope from a tiny player. J Pharmacol Pharmacother. 2012;3(3):217. doi: 10.4103/0976-500X.99416 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Naya FJ, Huang H-P, Qiu Y, et al. Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice. Genes Dev. 1997;11(18):2323–2334. doi: 10.1101/gad.11.18.2323 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Andrali SS, Qian Q, Özcan S. Glucose mediates the translocation of NeuroD1 by O-linked glycosylation. J Biol Chem. 2007;282(21):15589–15596. doi: 10.1074/jbc.M701762200 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from International Journal of General Medicine are provided here courtesy of Dove Press

RESOURCES